March 2018
·
15 Reads
·
5 Citations
Journal of the American College of Cardiology
This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.
March 2018
·
15 Reads
·
5 Citations
Journal of the American College of Cardiology
March 2018
·
5 Reads
Journal of the American College of Cardiology
March 2018
·
5 Reads
Journal of the American College of Cardiology
March 2018
·
8 Reads
Journal of the American College of Cardiology
March 2018
·
6 Reads
Journal of the American College of Cardiology
March 2018
·
4 Reads
Journal of the American College of Cardiology
August 2017
·
51 Reads
·
155 Citations
Rheumatology and Therapy
Management and therapy of rheumatoid arthritis (RA) has been revolutionized by the development and approval of the first biological disease-modifying antirheumatic drugs (bDMARDs) targeting tumor necrosis factor (TNF) α at the end of the last century. Today, numerous efficacious agents with different modes of action are available and achievement of clinical remission or, at least, low disease activity is the target of therapy. Early therapeutic interventions aiming at a defined goal of therapy (treat to target) are supposed to halt inflammation, improving symptoms and signs, and preserving structural integrity of the joints in RA. Up to now, bDMARDs approved for therapy in RA include agents with five different modes of action: TNF inhibition, T cell co-stimulation blockade, IL-6 receptor inhibition, B cell depletion, and interleukin 1 inhibition. Furthermore, targeted synthetic DMARDs (tsDMARDs) inhibiting Janus kinase (JAK) and biosimilars also are approved for RA. The present review focuses on bDMARDs and tsDMARDS regarding similarities and possible drug-specific advantages in the treatment of RA. Furthermore, compounds not yet approved in RA and biosimilars are discussed. Following the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) recommendations, specific treatment of the disease will be discussed with respect to safety and efficacy. In particular, we discuss the question of favoring specific bDMARDs or tsDMARDs in the two settings of insufficient response to methotrexate and to the first bDMARD, respectively.
August 2017
·
10 Reads
·
1 Citation
Atherosclerosis
August 2017
·
8 Reads
Atherosclerosis
August 2017
·
14 Reads
Atherosclerosis
... 11 Patients with both diabetes and CKD are at higher risk of cardiovascular morbidities and mortality, kidney failure, and death when compared with those without CKD. 12,13 Ethiopia is facing a double burden from communicable and noncommunicable diseases. Noncommunicable diseases and injuries account for 52% of the total mortality in 2016 in Ethiopia. ...
March 2018
Journal of the American College of Cardiology
... Targeted synthetic tsDMARDs, including JAK inhibitors, act by blocking intracellular signaling pathways to control inflammation. 3 On the other hand, treatment options are determined according to the conditions of each country. In Turkey, while csDMARDs are recommended in the first phase, advanced therapies can be used without sequencing in case of ineffectiveness or intolerance. ...
August 2017
Rheumatology and Therapy
... In this study, levels of maltose, lactose and sucrose were increased in the FLHS group. Glucose metabolism was found to be up-regulated in the liver of mice or human with NAFLD (Saely et al., 2017;Lu et al., 2020). Moreover, fasting glucose concentrations were also significantly elevated in the layers fed with high-energy low-protein diet (Zhuang et al., 2019). ...
August 2017
Atherosclerosis
... Only few studies have also looked at this question assessing uromodulin in urine, but with contradictory results. One study showed that the serum uromodulin is significantly associated with impaired glucose metabolism and the development of diabetes (Leiherer et al, 2017). Other study concluded that serum uromodulin concentrations are closely correlated with estimated Glomerular Filtration Rate, which is the recommended measure of renal function (Steubl et al, 2016). ...
August 2017
Atherosclerosis
... (22) Desde el enfoque comunitario, se hace necesario el fortalecimiento de los programas de Atención Primaria de Salud (APS), con énfasis en el retardo del daño renal, se debe tener presente que la tasa de filtrado glomerular, puede disminuir por tres causas principales: pérdida del número de nefronas con daño al tejido renal; disminución sin descenso en el número total de nefronas; y por procesos combinados con pérdida del número y disminución de la función. (23) La ERC es una problemática de salud que potencializa la importancia del trabajo interdisciplinario, la contribución social con respecto a la participación de las personas sobre el cuidado de su propia salud, la institucionalización de programas preventivos y un mayor nivel de cooperación entre el equipo de salud para la prevención y retardo de la ERC, son imperativos. (23) Debe tenerse en cuenta el papel que juega el primer nivel de atención en el tratamiento de pacientes crónicos porque al ser el primer contacto de atención genera la responsabilidad de educar al paciente y crearle conciencia de la importancia del adecuado control y de cumplir al pie de la letra las medidas generales con el propósito de evitar la evolución de la ERC, o en su caso retardar, la aparición de complicaciones propias de su enfermedad. ...
August 2017
Atherosclerosis
... As TRLs are cholesterol-rich, RC has attracted attention for its pathogenic capability due to a recently proposed concept-that of cholesterol toxicity-and this has engendered novel perspectives on the development of DM [34]. Previous cohort studies of the general population and coronary artery disease patients suggested that RC was a predictor of new-onset hyperglycemia, superior to other traditional lipid parameters [17,18,35]. Another study conducted in a kidney transplant cohort also demonstrated a significant association of baseline RC with new onset diabetes after transplantation [36]. ...
March 2017
Journal of the American College of Cardiology
... Alanine aminotransferase (ALT) is mainly found in hepatocytes, while aspartate aminotransferase (AST) mainly exists in the myocardium, followed by liver, kidney, and other tissues (Smith et al., 2020). Generally, the content of serum AST is low, but AST will be released into the blood when cells are injured, thus, AST is often used as a serum enzyme index for the diagnosis of liver injury (Vonbank et al., 2015;Li, 2020). Determination of serum ALT, AST, TG, and other indexes is FIGURE 4 | Isoorientin can reduce the oxidative damage of cells induced by oleic acid. ...
September 2016
Atherosclerosis
... Thus far, there is no report that indicates a direct correlation between BMI and Lp(a). However, some studies indicated a negative correlation between metabolic syndrome and serum Lp(a), and several prospective cohort studies reported that individuals with metabolic syndrome have significantly lower Lp(a) levels than those without metabolic syndrome [30][31][32] . ...
June 2016
The Journal of Clinical Endocrinology and Metabolism
... They also offer a favorable safety profile, making them ideal for patient's intolerant to statins [73]. trials [91]. Existing literature suggests the role of ApoB in individuals with low HDL-c, a history of ASCVD, T2DM, and hypertriglyceridemia for cardiovascular risk stratification [88,92]. ...
February 2016
Vascular Pharmacology
... Previous studies showed the association of hand grip strength with heart failure and cardiovascular risks such as high blood pressure, high blood sugar and lipid levels [51,52]. Hand grip strength in patients with type 2 diabetes is inversely associated with CVD independently from well-established cardiovascular risks [53]. A prospective study from the UK also showed hand grip strength has inverse associations with incidence of cardiovascular events [54]. ...
November 2015
Wiener klinische Wochenschrift